Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Warner-Lambert and BioChem Therapeutic seek potent and selective thrombin inhibitors

Dec. 30, 1998

Broader indication for Agrylin approved by FDA

Dec. 22, 1998

Orally bioavailable serine protease inhibitors for thrombotic disorders designed at Akzo

Dec. 22, 1998

Pharmacia & Upjohn to copromote Pletal tablets with Otsuka

Dec. 21, 1998

Corvas/Schering-Plough oral anticoagulant alliance extended

Dec. 21, 1998

New hemophilia treatment one step closer to market

Dec. 15, 1998

Anticoagulant cyclic diaza compounds reported by Cor Therapeutics

Dec. 15, 1998

First launch for Novartis anticoagulant takes place in Germany

Dec. 15, 1998

Novel anticoagulant serpin described by U.S. academics

Dec. 14, 1998

Avigen presents results of preclinical testing of hemophilia gene therapy and plans clinical trials

Dec. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...